Lantheus Holdings (LNTH) Shares Outstanding (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Shares Outstanding (Entity) of $72.3 million for Q1 2026, up 0.99% year-over-year from $71.6 million in Q1 2025, and up 0.68% quarter-over-quarter from $71.8 million in Q4 2025.
Lantheus Holdings (LNTH) Shares Outstanding (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Shares Outstanding (Entity) for 13 consecutive years, with $72.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.99% year-over-year to $72.3 million; the TTM figure through Mar 2026 stood at $72.3 million (up 0.99% YoY), while the FY2025 annual figure was $71.8 million, up 1.3% from the prior year.
- Shares Outstanding (Entity) advanced to $72.3 million in Q1 2026 per LNTH's latest filing, from $71.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $72.3 million in Q1 2026 and bottomed at $68.6 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $70.4 million across 5 years, with a median of $70.6 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 1.7% — and 2026, when it rose 0.99%.
- Lantheus Holdings' Shares Outstanding (Entity) stood at $68.9 million in 2022, then climbed by 1.47% to $69.9 million in 2023, then rose by 1.49% to $70.9 million in 2024, then increased by 1.3% to $71.8 million in 2025, then advanced by 0.68% to $72.3 million in 2026.
- Business Quant data shows LNTH's Shares Outstanding (Entity) at $72.3 million in Q1 2026, $71.8 million in Q4 2025, and $71.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 65.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.16 Mn |
| Mar 31, 2026 | 64.74 Mn |
| Dec 31, 2025 | 67.49 Mn |
| Sep 30, 2025 | 67.23 Mn |
| Jun 30, 2025 | 68.52 Mn |
| Mar 31, 2025 | 68.68 Mn |
| Dec 31, 2024 | 69.20 Mn |
| Sep 30, 2024 | 69.46 Mn |
| Jun 30, 2024 | 69.36 Mn |
| Mar 31, 2024 | 68.76 Mn |
| Dec 31, 2023 | 68.27 Mn |
| Sep 30, 2023 | 68.44 Mn |
| Jun 30, 2023 | 68.37 Mn |
| Mar 31, 2023 | 67.75 Mn |
| Dec 31, 2022 | 68.49 Mn |
| Sep 30, 2022 | 68.76 Mn |
| Jun 30, 2022 | 68.67 Mn |
| Mar 31, 2022 | 68.01 Mn |
| Dec 31, 2021 | 67.49 Mn |
| Sep 30, 2021 | 67.62 Mn |